Phase II Study: Integrated Palliative Care in Newly Diagnosed Advanced Non–Small-Cell Lung Cancer Patients
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Purpose: To assess the feasibility of early palliative care in the ambulatory setting in patients with newly diagnosed advanced non–small-cell lung cancer (NSCLC). Patients and Methods: Patients were eligible if they had a performance status of 0 to 1 and were within 8 weeks of diagnosis of advanced NSCLC. Participants received integrated care from oncology and palliative care throughout the course of their disease. Participants were scheduled to meet with the palliative care team (PCT) and complete quality-of–life (QOL) and mood questionnaires monthly for 6 months. The study was deemed feasible if 64% of patients completed at least 50% of their scheduled visits and QOL assessments. Results: Fifty-one patients were enrolled onto the trial. One died within 72 hours and was not assessable. Ninety percent (95% CI, 0.78 to 0.96) of study participants complied with at least 50% of the palliative care visits. Eight-six percent (95% CI, 0.73 to 0.94) of the participants met the full feasibility requirements by both meeting with the PCT and completing QOL assessments at least 50% of the time. QOL and mood analyses confirmed the high symptom burden in patients with newly diagnosed advanced NSCLC. At least 50% of participants experienced some degree of shortness of breath, cough, difficulty breathing, appetite loss, weight loss, or unclear thinking at their baseline assessment. More than one third of patients had a probable mood disorder at baseline. Conclusion: Integrated palliative and oncology care is feasible in ambulatory patients with advanced NSCLC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
Shepherd, F. A., Rodrigues Pereira, J., Ciuleanu, T., Tan, E. H., Hirsh, V., Thongprasert, S., Campos, D., Maoleekoonpiroj, S., Smylie, M., Martins, R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050753 · Cited by 5,419
Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
Schiller, J. H., Harrington, D., Belani, C. P., Langer, C., Sandler, A., Krook, J., Zhu, J., & Johnson, D. H. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011954 · Cited by 4,955
Kris, M. G., Natale, R. B., Herbst, R. S., Lynch, Jr., Prager, D., Belani, C. P., Schiller, J. H., Kelly, K., Spiridonidis, H., Sandler, A., et al. (2003) · JAMA · doi:10.1001/jama.290.16.2149 · Cited by 2,517
Hanna, N., Shepherd, F. A., Fossella, F. V., Pereira, J. R., De Marinis, F., von Pawel, J., Gatzemeier, U., Tsao, T. C. Y., Pless, M., Muller, T., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.163 · Cited by 2,426
Yellen, S. B., Cella, D. F., Webster, K., Blendowski, C., & Kaplan, E. (1997) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(96)00274-6 · Cited by 1,964
Cited by
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
Temel, J. S., Greer, J. A., Muzikansky, A., Gallagher, E. R., Admane, S., Jackson, V. A., Dahlin, C. M., Blinderman, C. D., Jacobsen, J., Pirl, W. F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000678 · Cited by 7,482
Self-citationBakitas, M., Lyons, K. D., Hegel, M. T., Balan, S., Brokaw, F. C., Seville, J., Hull, J. G., Li, Z., Tosteson, T. D., Byock, I. R., et al. (2009) · JAMA · doi:10.1001/jama.2009.1198 · Cited by 1,726
Temel, J. S., Greer, J. A., El-Jawahri, A., Pirl, W. F., Park, E. R., Jackson, V. A., Back, A. L., Kamdar, M., Jacobsen, J., Chittenden, E. H., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.5046 · Cited by 836
Self-citationGomes, B., Calanzani, N., Curiale, V., McCrone, P., Higginson, I. J., & de Brito, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007760.pub2 · Cited by 785
Early palliative care for adults with advanced cancer
Haun, M. W., Estel, S., Rücker, G., Friederich, H.-C., Villalobos, M., Thomas, M., & Hartmann, M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011129.pub2 · Cited by 757
Temel, J. S., Greer, J. A., Admane, S., Gallagher, E. R., Jackson, V. A., Lynch, T. J., Lennes, I. T., Dahlin, C. M., & Pirl, W. F. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.4459 · Cited by 696
Self-citationGreer, J. A., Pirl, W. F., Jackson, V. A., Muzikansky, A., Lennes, I. T., Heist, R. S., Gallagher, E. R., & Temel, J. S. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.7996 · Cited by 574
Self-citationAvailability and Integration of Palliative Care at US Cancer Centers
Hui, D. (2010) · JAMA · doi:10.1001/jama.2010.258 · Cited by 495
Effectiveness of Specialized Palliative Care: A Systematic Review
Zimmermann, C., Riechelmann, R., Krzyzanowska, M., Rodin, G., & Tannock, I. (2008) · JAMA · doi:10.1001/jama.299.14.1698 · Cited by 468
Greer, J. A., Jackson, V. A., Meier, D. E., & Temel, J. S. (2013) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21192 · Cited by 345
Self-citationReferral criteria for outpatient specialty palliative cancer care: an international consensus
Hui, D., Mori, M., Watanabe, S. M., Caraceni, A., Strasser, F., Saarto, T., Cherny, N., Glare, P., Kaasa, S., & Bruera, E. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30577-0 · Cited by 301
Early Palliative Care in Advanced Lung Cancer: A Qualitative Study
Yoong, J., Park, E. R., Greer, J. A., Jackson, V. A., Gallagher, E. R., Pirl, W. F., Back, A. L., & Temel, J. S. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1874 · Cited by 284
Self-citationNipp, R. D., El‐Jawahri, A., Fishbein, J. N., Eusebio, J., Stagl, J. M., Gallagher, E. R., Park, E. R., Jackson, V. A., Pirl, W. F., Greer, J. A., et al. (2016) · Cancer · doi:10.1002/cncr.30025 · Cited by 283
Self-citationThe Role of Chemotherapy at the End of Life: “When Is Enough, Enough?”
Harrington, S. E., & Smith, T. J. (2008) · JAMA · doi:10.1001/jama.299.22.2667 · Cited by 280
Integration of Oncology and Palliative Care: A Systematic Review
Hui, D., Kim, Y. J., Park, J. C., Zhang, Y., Strasser, F., Cherny, N., Kaasa, S., Davis, M. P., & Bruera, E. (2015) · The Oncologist · doi:10.1634/theoncologist.2014-0312 · Cited by 188
Bakitas, M., Lyons, K. D., Hegel, M. T., Balan, S., Barnett, K. N., Brokaw, F. C., Byock, I. R., Hull, J. G., Li, Z., Mckinstry, E., et al. (2009) · Palliative and Supportive Care · doi:10.1017/s1478951509000108 · Cited by 188
“Some authors have provided guidance on conducting palliative care descriptive studies (Hopkinson et al., 2005; Steinhauser et al., 2006; Hinds et al., 2007; Temel et al., 2007) and randomized controlled trials (RCTs) (Jordhoy et al.”
BackgroundInfluentialJacobsen, J., Jackson, V., Dahlin, C., Greer, J., Perez-Cruz, P., Billings, J. A., Pirl, W., & Temel, J. (2011) · Journal of Palliative Medicine · doi:10.1089/jpm.2010.0382 · Cited by 182
Self-citationWorking With a Palliative Care Team
Wiebe, L. A., & Von Roenn, J. H. (2010) · The Cancer Journal · doi:10.1097/ppo.0b013e3181f28ae6 · Cited by 24
Metadata
- Authors
- Temel, J. S., Jackson, V. A., Billings, J. A., Dahlin, C., Block, S. D., Buss, M. K., Ostler, P., Fidias, P., Muzikansky, A., Greer, J. A., Pirl, W. F., & Lynch, T. J.
- Venue
- Journal of Clinical Oncology
- Published
- 2007-06-10
- Volume
- 25
- Issue
- 17
- Pages
- 2377-2382
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2123498311
- Cited by
- 143
- References
- 5
- FWCI
- 10.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.